Skip to main content
GDU GI 2023 Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Wednesday, August 2, 2023
  • 8:00 AM – 8:15 AM ET
    Welcome
  • 8:15 AM – 8:30 AM ET
    1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant Immunotherapy
  • 8:30 AM – 8:45 AM ET
    1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant Immunotherapy
  • 8:45 AM – 9:00 AM ET
    1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers
  • 9:00 AM – 9:15 AM ET
    Break
  • 9:15 AM – 9:30 AM ET
    Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined Immunotherapy
  • 9:30 AM – 9:45 AM ET
    Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Chemotherapy
  • 9:45 AM – 10:00 AM ET
    Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC)
  • 10:00 AM – 10:15 AM ET
    Break
  • 10:15 AM – 11:15 AM ET
    Non-CME Innvoation Theater
  • 11:15 AM – 11:30 AM ET
    Break
  • 11:30 AM – 12:15 PM ET
    Session 3: Targeted Agents in Colorectal Cancer: An Update
    Presenter: Heinz-Josef Lenz, MD – University of Southern California
  • 12:15 PM – 12:30 PM ET
    Break
  • 12:30 PM – 1:15 PM ET
    Session 4: Deciphering Appendiceal Cancer
    Presenter: Deepa Magge, MD, FACS – Vanderbilt-Ingram Cancer Center
  • 1:15 PM – 1:30 PM ET
    Break
  • 1:30 PM – 2:30 PM ET
    Non-CME Innvoation Theater
  • 2:30 PM – 2:45 PM ET
    Break
  • 2:45 PM – 3:30 PM ET
    Session 5: Clinical Trial Landscape Incorporating ctDNA
    Presenter: Pashtoon M. Kasi, MD, MS – Weill Cornell Medicine/NewYork-Presbyterian; Englander Institute of Precision Medicine
  • 3:30 PM – 3:45 PM ET
    Break
  • 3:45 PM – 4:20 PM ET
    6 - Session 6: Integration of Supportive Care
  • 4:20 PM – 4:30 PM ET
    6 - Live Q&A
  • 4:30 PM – 4:45 PM ET
    Break
  • 4:45 PM – 5:20 PM ET
    7 - Session 7: Perspectives on Clinical Trial Development in Anal Cancer
  • 5:20 PM – 5:30 PM ET
    7 - Live Q&A
  • Thursday, August 3, 2023
  • 8:00 AM – 8:15 AM ET
    Welcome
  • 8:15 AM – 8:30 AM ET
    8 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided All RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Triplet Chemo + Bevacizumab
  • 8:30 AM – 8:45 AM ET
    8 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Doublet Chemo + Panitumumab
  • 8:45 AM – 9:00 AM ET
    9 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Discussion
  • 9:00 AM – 9:15 AM ET
    Break
  • 9:15 AM – 9:50 AM ET
    Session 9: Integrating Biomarkers into the Management of Gastric Cancer: A Focus on Molecular Testing and Targeted Treatment Strategies
  • 9:50 AM – 10:00 AM ET
    Live Q&A
  • 10:00 AM – 10:15 AM ET
    Break
  • 10:15 AM – 11:15 AM ET
    Non-CME Innvoation Theater
  • 11:15 AM – 11:30 AM ET
    Break
  • 11:30 AM – 12:05 PM ET
    10 - Session 10: Therapeutic Sequencing in Advanced Colorectal Cancer: New Strategies from Clinical Trial Data
    Presenter: Aaron J. Scott, MD – University of Arizona Cancer Center
  • 12:05 PM – 12:15 PM ET
    10 - Live Q&A
    Moderator: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
    Speaker: Aaron J. Scott, MD – University of Arizona Cancer Center
  • 12:15 PM – 12:30 PM ET
    Break
  • 12:30 PM – 1:05 PM ET
    11 - Session 11: Updates from Recent Meetings
    Presenter: Eric Van Cutsem, MD, PhD – University Hospitals Leuven / KU Leuven
  • 1:05 PM – 1:15 PM ET
    11 - Live Q&A
    Moderator: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
    Speaker: Eric Van Cutsem, MD, PhD – University Hospitals Leuven / KU Leuven
  • 1:15 PM – 1:30 PM ET
    Break
  • 1:30 PM – 2:30 PM ET
    Non-CME Innvoation Theater
  • 2:30 PM – 2:45 PM ET
    Break
  • 2:45 PM – 3:00 PM ET
    12 - Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRT
  • 3:00 PM – 3:15 PM ET
    12 - Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Chemotherapy
  • 3:15 PM – 3:30 PM ET
    12 - Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy
  • 3:30 PM – 3:45 PM ET
    Break
  • 3:45 PM – 4:20 PM ET
    13 - Session 13: The Pillars of Cancer Wellness
  • 4:20 PM – 4:30 PM ET
    13 - Live Q&A
  • 4:30 PM – 4:45 PM ET
    Break
  • 4:45 PM – 5:20 PM ET
    14 - Session 14: The Power of Patient Advocacy
  • 5:20 PM – 5:30 PM ET
    14 - Live Q&A
  • Friday, August 4, 2023
  • 9:00 AM – 9:15 AM ET
    Welcome
  • 9:15 AM – 9:30 AM ET
    18 - Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - FOLFIRINOX
  • 9:30 AM – 9:45 AM ET
    18 - Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOX
  • 9:45 AM – 10:00 AM ET
    18 - Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer
  • 10:00 AM – 10:15 AM ET
    Break
  • 10:15 AM – 10:30 AM ET
    15 - Session 16: Debate: Is There a Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Yes
  • 10:30 AM – 10:45 AM ET
    15 - Session 16: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - No
  • 10:45 AM – 11:00 AM ET
    15 - Session 16: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Discussion
  • 11:00 AM – 11:15 AM ET
    Break
  • 11:15 AM – 11:50 AM ET
    19 - Session 17: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment Strategies
  • 11:50 AM – 12:00 PM ET
    19 - Live Q&A
  • 12:15 PM – 12:30 PM ET
    Break
  • 12:30 PM – 1:05 PM ET
    21 - Session 18: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
  • 1:05 PM – 1:15 PM ET
    21 - Live Q&A
  • 1:15 PM – 1:30 PM ET
    Break
  • 1:30 PM – 2:15 PM ET
    Session 19: Determination of Treatment Patterns in HCC
    Presenter: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
  • 2:15 PM – 2:30 PM ET
    Break
  • 2:30 PM – 3:15 PM ET
    Session 20: Role of Interventional Radiology in the Management of NETs
    Presenter: Nishita Kothary, MD – Stanford School of Medicine
  • 3:15 PM – 3:30 PM ET
    Break
  • 3:30 PM – 4:15 PM ET
    20 - Session 21: Significance of Cancer Genetics
  • 4:15 PM – 4:20 PM ET
    20 - Closing Remarks
  • On Demand
  • On-Demand
    Augmenting Standard Treatment Options in Pancreatic Cancer
    Presenter: Rachna Shroff, MD – The University of Arizona Cancer Center
  • On-Demand
    Colon Cancer Update in Adjuvant Therapy
    Presenter: Aparna Parikh, MD, MS – Harvard Medical School; Massachusetts General Hospital
  • On-Demand
    Critical Pathways in Metastatic Colorectal Cancer
    Presenter: Ryan Corcoran, MD, PhD – MGH Cancer Center
  • On-Demand
    Emerging Targets in Upper Gastrointestinal Tract (UGI) Cancers

    Presenter: Sam Klempner, MD – Mass General Cancer Center

  • On-Demand
    The Emerging Role of Checkpoint Inhibitor Therapy in Locally Advanced Esophagogastric Cancer
    Presenter: Jennifer R. Eads, MD – University of Pennsylvania, Abramson Cancer Center